| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreas | 76 | 2019 | 737 | 5.390 |
Why?
|
| Pancreatic Neoplasms | 85 | 2024 | 5258 | 4.560 |
Why?
|
| Carcinoma, Pancreatic Ductal | 27 | 2024 | 1831 | 3.270 |
Why?
|
| Pancreatitis | 16 | 2019 | 294 | 2.580 |
Why?
|
| Sincalide | 28 | 2012 | 38 | 2.400 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 14 | 2024 | 1404 | 2.170 |
Why?
|
| Receptors, Cholecystokinin | 24 | 2008 | 29 | 1.910 |
Why?
|
| NF-kappa B | 18 | 2018 | 1555 | 1.700 |
Why?
|
| Calcium-Binding Proteins | 8 | 2013 | 541 | 1.540 |
Why?
|
| Acinar Cells | 7 | 2019 | 56 | 1.530 |
Why?
|
| Cholecystokinin | 24 | 2010 | 51 | 1.480 |
Why?
|
| Neoplasm Proteins | 13 | 2016 | 3345 | 1.430 |
Why?
|
| Receptors, Immunologic | 6 | 2012 | 310 | 1.350 |
Why?
|
| Trypsin | 6 | 2019 | 155 | 1.320 |
Why?
|
| Receptor for Advanced Glycation End Products | 10 | 2017 | 39 | 1.290 |
Why?
|
| Genes, ras | 7 | 2016 | 678 | 1.110 |
Why?
|
| Animals | 166 | 2024 | 61340 | 1.110 |
Why?
|
| Antigens, Surface | 4 | 2016 | 304 | 1.090 |
Why?
|
| Trypsinogen | 8 | 2019 | 9 | 1.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 32 | 2020 | 9048 | 1.020 |
Why?
|
| Deoxycytidine | 8 | 2020 | 1389 | 1.010 |
Why?
|
| Pancreas, Exocrine | 6 | 2018 | 23 | 0.980 |
Why?
|
| Pancreatitis, Chronic | 7 | 2018 | 127 | 0.980 |
Why?
|
| Receptors, Muscarinic | 10 | 1999 | 72 | 0.940 |
Why?
|
| Mice | 82 | 2024 | 35414 | 0.840 |
Why?
|
| Cell Line, Tumor | 42 | 2020 | 14878 | 0.800 |
Why?
|
| Gene Expression | 15 | 2019 | 3606 | 0.800 |
Why?
|
| Pancreatic Stellate Cells | 11 | 2018 | 78 | 0.800 |
Why?
|
| Bombesin | 10 | 2007 | 19 | 0.790 |
Why?
|
| Mice, Nude | 23 | 2019 | 4332 | 0.780 |
Why?
|
| Adenocarcinoma | 19 | 2013 | 7920 | 0.780 |
Why?
|
| RNA, Messenger | 37 | 2015 | 6344 | 0.770 |
Why?
|
| Endoplasmic Reticulum | 3 | 2008 | 330 | 0.750 |
Why?
|
| Amylases | 20 | 2008 | 67 | 0.730 |
Why?
|
| RNA, Small Interfering | 13 | 2019 | 2192 | 0.720 |
Why?
|
| Cromolyn Sodium | 2 | 2013 | 6 | 0.720 |
Why?
|
| Signal Transduction | 35 | 2019 | 12033 | 0.700 |
Why?
|
| Rats | 48 | 2012 | 6396 | 0.700 |
Why?
|
| Peptides | 6 | 2014 | 1502 | 0.670 |
Why?
|
| Cell Transformation, Neoplastic | 8 | 2019 | 2454 | 0.670 |
Why?
|
| Adrenomedullin | 3 | 2012 | 106 | 0.660 |
Why?
|
| S100 Proteins | 2 | 2012 | 184 | 0.660 |
Why?
|
| Inflammation | 7 | 2024 | 2491 | 0.640 |
Why?
|
| Cell Division | 24 | 2004 | 2657 | 0.640 |
Why?
|
| Adaptive Immunity | 1 | 2019 | 151 | 0.610 |
Why?
|
| Receptors, Peptide | 2 | 2009 | 87 | 0.610 |
Why?
|
| Cathepsin E | 3 | 2013 | 6 | 0.610 |
Why?
|
| ras Proteins | 6 | 2024 | 804 | 0.600 |
Why?
|
| Mitogen-Activated Protein Kinases | 8 | 2008 | 667 | 0.590 |
Why?
|
| Gastrins | 7 | 2004 | 55 | 0.580 |
Why?
|
| Pancreatic Ducts | 8 | 2020 | 127 | 0.580 |
Why?
|
| Transgenes | 1 | 2019 | 568 | 0.580 |
Why?
|
| Xenograft Model Antitumor Assays | 12 | 2017 | 3929 | 0.550 |
Why?
|
| Apoptosis | 14 | 2015 | 7755 | 0.550 |
Why?
|
| Carbachol | 12 | 1999 | 33 | 0.550 |
Why?
|
| Cell Proliferation | 25 | 2017 | 7232 | 0.540 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 19 | 2016 | 3582 | 0.540 |
Why?
|
| Proto-Oncogene Proteins | 6 | 2020 | 2618 | 0.530 |
Why?
|
| Calcium | 14 | 2004 | 1569 | 0.520 |
Why?
|
| Proteins | 7 | 2015 | 2030 | 0.520 |
Why?
|
| Diagnostic Imaging | 3 | 2014 | 1174 | 0.500 |
Why?
|
| Cell Movement | 9 | 2017 | 2468 | 0.500 |
Why?
|
| Drug Resistance, Multiple | 1 | 2015 | 221 | 0.490 |
Why?
|
| Rats, Wistar | 12 | 2006 | 598 | 0.480 |
Why?
|
| Metaplasia | 1 | 2016 | 387 | 0.480 |
Why?
|
| Gene Expression Regulation | 14 | 2013 | 4102 | 0.480 |
Why?
|
| Ceruletide | 10 | 2016 | 28 | 0.480 |
Why?
|
| Neoplasm Invasiveness | 14 | 2020 | 4054 | 0.470 |
Why?
|
| Mice, Transgenic | 18 | 2020 | 4198 | 0.470 |
Why?
|
| Stress, Physiological | 2 | 2008 | 489 | 0.460 |
Why?
|
| Transcription Factor RelA | 3 | 2012 | 184 | 0.450 |
Why?
|
| Receptors, Bombesin | 5 | 1999 | 11 | 0.450 |
Why?
|
| Gene Transfer Techniques | 5 | 2019 | 800 | 0.450 |
Why?
|
| MAP Kinase Signaling System | 6 | 2020 | 884 | 0.450 |
Why?
|
| RNA Interference | 12 | 2020 | 1381 | 0.440 |
Why?
|
| Cyclooxygenase 2 | 5 | 2019 | 495 | 0.440 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 10 | 2011 | 2477 | 0.430 |
Why?
|
| Cell Adhesion Molecules | 4 | 2019 | 564 | 0.420 |
Why?
|
| Enzyme Activation | 14 | 2011 | 1801 | 0.420 |
Why?
|
| Down-Regulation | 12 | 2020 | 2087 | 0.420 |
Why?
|
| Humans | 110 | 2020 | 270637 | 0.420 |
Why?
|
| CA-19-9 Antigen | 3 | 2008 | 155 | 0.410 |
Why?
|
| Lactic Acid | 1 | 2014 | 312 | 0.410 |
Why?
|
| Glucocorticoids | 9 | 1992 | 610 | 0.410 |
Why?
|
| Cells, Cultured | 35 | 2013 | 5657 | 0.410 |
Why?
|
| Receptors, G-Protein-Coupled | 4 | 2014 | 485 | 0.400 |
Why?
|
| Neoplasms | 10 | 2019 | 15949 | 0.400 |
Why?
|
| Feedback, Physiological | 2 | 2012 | 191 | 0.400 |
Why?
|
| Transforming Growth Factor beta | 6 | 2006 | 1105 | 0.400 |
Why?
|
| Precancerous Conditions | 4 | 2020 | 1061 | 0.390 |
Why?
|
| DNA-Binding Proteins | 10 | 2009 | 4992 | 0.390 |
Why?
|
| Diet, High-Fat | 3 | 2019 | 244 | 0.380 |
Why?
|
| Protein Binding | 15 | 2020 | 3472 | 0.380 |
Why?
|
| Cytokines | 7 | 2017 | 2803 | 0.370 |
Why?
|
| Drug Resistance, Neoplasm | 10 | 2020 | 5417 | 0.360 |
Why?
|
| Transfection | 17 | 2014 | 3109 | 0.350 |
Why?
|
| Insulin | 12 | 2012 | 1423 | 0.350 |
Why?
|
| Gastrointestinal Tract | 1 | 2013 | 322 | 0.350 |
Why?
|
| Oncogenes | 3 | 2020 | 697 | 0.340 |
Why?
|
| Gene Silencing | 4 | 2018 | 825 | 0.340 |
Why?
|
| Disease Models, Animal | 16 | 2020 | 7317 | 0.340 |
Why?
|
| Tumor Cells, Cultured | 21 | 2014 | 5759 | 0.340 |
Why?
|
| Carcinoma in Situ | 2 | 2020 | 489 | 0.330 |
Why?
|
| Mutation | 16 | 2024 | 15917 | 0.330 |
Why?
|
| Antimetabolites, Antineoplastic | 4 | 2008 | 1347 | 0.330 |
Why?
|
| Biomarkers, Tumor | 10 | 2020 | 10725 | 0.330 |
Why?
|
| Cation Transport Proteins | 4 | 2013 | 168 | 0.330 |
Why?
|
| Integrases | 3 | 2011 | 254 | 0.320 |
Why?
|
| Stromal Cells | 4 | 2017 | 823 | 0.320 |
Why?
|
| Antineoplastic Agents | 9 | 2020 | 14638 | 0.320 |
Why?
|
| Trans-Activators | 5 | 2011 | 1626 | 0.320 |
Why?
|
| Blood Proteins | 2 | 2017 | 297 | 0.320 |
Why?
|
| Gene Expression Profiling | 12 | 2012 | 5144 | 0.320 |
Why?
|
| Neoplasm Metastasis | 8 | 2017 | 5332 | 0.310 |
Why?
|
| Immunohistochemistry | 17 | 2016 | 7646 | 0.310 |
Why?
|
| Genes, Reporter | 4 | 2013 | 813 | 0.310 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2008 | 127 | 0.310 |
Why?
|
| Paracrine Communication | 4 | 2018 | 128 | 0.300 |
Why?
|
| Lactose | 3 | 2014 | 66 | 0.290 |
Why?
|
| CHO Cells | 12 | 2001 | 320 | 0.290 |
Why?
|
| Up-Regulation | 8 | 2017 | 2412 | 0.290 |
Why?
|
| Peptide Fragments | 3 | 2012 | 1309 | 0.290 |
Why?
|
| Gene Expression Regulation, Enzymologic | 4 | 2020 | 690 | 0.290 |
Why?
|
| Epidermal Growth Factor | 7 | 1995 | 440 | 0.290 |
Why?
|
| Ornithine Decarboxylase | 3 | 1992 | 35 | 0.280 |
Why?
|
| Peritoneal Neoplasms | 1 | 2014 | 866 | 0.280 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 5 | 1999 | 222 | 0.280 |
Why?
|
| Pancreatitis, Alcoholic | 1 | 2006 | 6 | 0.280 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2007 | 232 | 0.270 |
Why?
|
| Receptor, Cholecystokinin A | 7 | 2010 | 8 | 0.270 |
Why?
|
| Ligands | 7 | 2012 | 1007 | 0.270 |
Why?
|
| Cricetinae | 13 | 2004 | 744 | 0.270 |
Why?
|
| Blotting, Western | 15 | 2013 | 3567 | 0.270 |
Why?
|
| DNA | 15 | 1999 | 3041 | 0.270 |
Why?
|
| Dexamethasone | 12 | 1996 | 1525 | 0.260 |
Why?
|
| Protein Folding | 1 | 2007 | 297 | 0.260 |
Why?
|
| Tumor Microenvironment | 6 | 2017 | 3054 | 0.260 |
Why?
|
| Male | 55 | 2016 | 128446 | 0.260 |
Why?
|
| Protein Array Analysis | 1 | 2008 | 503 | 0.260 |
Why?
|
| Neoplasm Transplantation | 5 | 2014 | 1553 | 0.260 |
Why?
|
| Quinazolines | 1 | 2010 | 956 | 0.250 |
Why?
|
| Adenoviridae | 12 | 2005 | 1490 | 0.250 |
Why?
|
| Vagus Nerve | 2 | 2008 | 70 | 0.250 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2019 | 3656 | 0.250 |
Why?
|
| Chronic Disease | 6 | 2016 | 1824 | 0.250 |
Why?
|
| Cell Survival | 8 | 2014 | 3057 | 0.250 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 4 | 2020 | 657 | 0.250 |
Why?
|
| Antigens, CD | 2 | 2007 | 1420 | 0.250 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 6 | 2013 | 596 | 0.250 |
Why?
|
| Corticosterone | 5 | 1989 | 121 | 0.240 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2011 | 1901 | 0.240 |
Why?
|
| Visceral Afferents | 1 | 2004 | 8 | 0.240 |
Why?
|
| Disease Progression | 10 | 2018 | 6880 | 0.240 |
Why?
|
| Transcription Factors | 7 | 2019 | 5415 | 0.240 |
Why?
|
| Promoter Regions, Genetic | 3 | 2011 | 3205 | 0.240 |
Why?
|
| Time Factors | 19 | 2017 | 12974 | 0.230 |
Why?
|
| Ethanol | 1 | 2006 | 271 | 0.230 |
Why?
|
| Dose-Response Relationship, Drug | 15 | 2007 | 5053 | 0.230 |
Why?
|
| Galectin 3 | 2 | 2017 | 131 | 0.230 |
Why?
|
| Kinetics | 15 | 2005 | 2206 | 0.230 |
Why?
|
| Carcinoma, Acinar Cell | 3 | 2009 | 87 | 0.230 |
Why?
|
| Neovascularization, Pathologic | 5 | 2014 | 1587 | 0.220 |
Why?
|
| Arginine | 2 | 2006 | 506 | 0.220 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 4 | 2013 | 196 | 0.220 |
Why?
|
| Chemokines | 3 | 2018 | 285 | 0.210 |
Why?
|
| Fibroblasts | 2 | 2012 | 1647 | 0.210 |
Why?
|
| Islets of Langerhans | 4 | 2011 | 233 | 0.210 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2015 | 492 | 0.200 |
Why?
|
| Thymidine | 10 | 2006 | 167 | 0.200 |
Why?
|
| Colonic Neoplasms | 6 | 2012 | 1435 | 0.200 |
Why?
|
| Receptors, Prostaglandin E, EP4 Subtype | 2 | 2013 | 23 | 0.200 |
Why?
|
| Nanoparticles | 2 | 2019 | 584 | 0.200 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2020 | 677 | 0.200 |
Why?
|
| Calcium Signaling | 4 | 2011 | 281 | 0.200 |
Why?
|
| Fluorine Radioisotopes | 2 | 2014 | 140 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-met | 2 | 2016 | 426 | 0.190 |
Why?
|
| DNA Primers | 3 | 2011 | 1489 | 0.190 |
Why?
|
| I-kappa B Kinase | 2 | 2012 | 247 | 0.190 |
Why?
|
| Intracellular Membranes | 1 | 2001 | 117 | 0.180 |
Why?
|
| Cell Separation | 4 | 2005 | 606 | 0.180 |
Why?
|
| Dinoprostone | 2 | 2013 | 219 | 0.180 |
Why?
|
| Pancreatic Diseases | 2 | 2011 | 113 | 0.180 |
Why?
|
| Recombinant Proteins | 10 | 2011 | 2986 | 0.180 |
Why?
|
| Subcellular Fractions | 2 | 2017 | 210 | 0.180 |
Why?
|
| Flow Cytometry | 4 | 2009 | 3040 | 0.170 |
Why?
|
| Mutation Rate | 1 | 2020 | 220 | 0.170 |
Why?
|
| Smad4 Protein | 5 | 2006 | 201 | 0.170 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2019 | 66 | 0.170 |
Why?
|
| Retinoblastoma Protein | 2 | 1999 | 339 | 0.170 |
Why?
|
| rho GTP-Binding Proteins | 2 | 2019 | 180 | 0.170 |
Why?
|
| Glutathione Transferase | 1 | 2020 | 364 | 0.170 |
Why?
|
| Lectins, C-Type | 3 | 2011 | 163 | 0.170 |
Why?
|
| Lysophospholipids | 3 | 2005 | 148 | 0.170 |
Why?
|
| Matrix Metalloproteinase 2 | 3 | 2016 | 259 | 0.160 |
Why?
|
| Molecular Sequence Data | 9 | 2014 | 6638 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 7 | 2018 | 7047 | 0.160 |
Why?
|
| Drug Design | 2 | 2013 | 371 | 0.160 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2008 | 1503 | 0.160 |
Why?
|
| Transcription, Genetic | 5 | 2017 | 3328 | 0.160 |
Why?
|
| Base Sequence | 8 | 2011 | 5405 | 0.160 |
Why?
|
| Transplantation, Heterologous | 5 | 2012 | 1050 | 0.160 |
Why?
|
| Receptors, Cell Surface | 5 | 2011 | 902 | 0.160 |
Why?
|
| Culture Media, Conditioned | 3 | 2013 | 254 | 0.160 |
Why?
|
| Lipocalin-2 | 2 | 2017 | 77 | 0.160 |
Why?
|
| Receptors, Adrenomedullin | 2 | 2009 | 25 | 0.160 |
Why?
|
| Endocytosis | 2 | 2020 | 228 | 0.160 |
Why?
|
| In Vitro Techniques | 6 | 2012 | 1695 | 0.160 |
Why?
|
| Immune System | 2 | 2017 | 275 | 0.160 |
Why?
|
| Immunoprecipitation | 4 | 2009 | 590 | 0.150 |
Why?
|
| Tissue Distribution | 2 | 2017 | 920 | 0.150 |
Why?
|
| Fibroblast Growth Factors | 2 | 2019 | 258 | 0.150 |
Why?
|
| Mucoproteins | 3 | 2019 | 22 | 0.150 |
Why?
|
| Species Specificity | 2 | 2015 | 783 | 0.150 |
Why?
|
| Threonine | 2 | 1995 | 163 | 0.150 |
Why?
|
| Radiopharmaceuticals | 3 | 2014 | 1342 | 0.150 |
Why?
|
| Luciferases | 3 | 2009 | 454 | 0.150 |
Why?
|
| Protein Kinase C | 1 | 2000 | 414 | 0.150 |
Why?
|
| GTP-Binding Proteins | 5 | 2004 | 340 | 0.150 |
Why?
|
| Gastric Mucosa | 4 | 1982 | 654 | 0.150 |
Why?
|
| DNA Methylation | 2 | 2007 | 2769 | 0.150 |
Why?
|
| Phosphorylation | 9 | 2010 | 4905 | 0.150 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 2 | 2011 | 155 | 0.150 |
Why?
|
| Azacitidine | 1 | 2004 | 1218 | 0.150 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2016 | 350 | 0.150 |
Why?
|
| Antigens, Neoplasm | 4 | 2011 | 1581 | 0.150 |
Why?
|
| Genes, Retinoblastoma | 1 | 1997 | 92 | 0.140 |
Why?
|
| Phenotype | 6 | 2017 | 6502 | 0.140 |
Why?
|
| Somatomedins | 3 | 1987 | 73 | 0.140 |
Why?
|
| Biomarkers | 2 | 2008 | 5048 | 0.140 |
Why?
|
| Pancreatitis-Associated Proteins | 4 | 2014 | 34 | 0.140 |
Why?
|
| Amino Acid Sequence | 7 | 2014 | 4532 | 0.140 |
Why?
|
| Obesity | 3 | 2019 | 2888 | 0.140 |
Why?
|
| Enzyme Inhibitors | 8 | 2010 | 1944 | 0.140 |
Why?
|
| Integrin beta1 | 1 | 2017 | 127 | 0.140 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2004 | 1623 | 0.140 |
Why?
|
| MCF-7 Cells | 2 | 2019 | 547 | 0.140 |
Why?
|
| Receptor, Insulin | 3 | 1989 | 102 | 0.140 |
Why?
|
| Immunoblotting | 4 | 2009 | 887 | 0.140 |
Why?
|
| NIH 3T3 Cells | 3 | 2010 | 254 | 0.140 |
Why?
|
| Guanidines | 3 | 2012 | 61 | 0.140 |
Why?
|
| Epithelial Cells | 6 | 2013 | 1875 | 0.140 |
Why?
|
| Proteolysis | 2 | 2020 | 378 | 0.140 |
Why?
|
| Membrane Proteins | 3 | 2019 | 2922 | 0.130 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2019 | 551 | 0.130 |
Why?
|
| Microscopy, Electron | 10 | 2005 | 697 | 0.130 |
Why?
|
| RNAi Therapeutics | 1 | 2016 | 44 | 0.130 |
Why?
|
| Cell Line | 13 | 2004 | 5313 | 0.130 |
Why?
|
| Oncogene Proteins | 3 | 2019 | 366 | 0.130 |
Why?
|
| Glycolysis | 1 | 2019 | 529 | 0.130 |
Why?
|
| Oocytes | 5 | 1992 | 413 | 0.130 |
Why?
|
| HCT116 Cells | 2 | 2014 | 354 | 0.130 |
Why?
|
| Thiocarbamates | 3 | 2001 | 17 | 0.130 |
Why?
|
| Reproducibility of Results | 4 | 2008 | 6192 | 0.130 |
Why?
|
| Multidrug Resistance-Associated Proteins | 1 | 2015 | 85 | 0.130 |
Why?
|
| Regeneration | 3 | 2016 | 283 | 0.130 |
Why?
|
| 3T3 Cells | 4 | 2019 | 385 | 0.130 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2007 | 2139 | 0.130 |
Why?
|
| Salivary Ducts | 1 | 2015 | 54 | 0.130 |
Why?
|
| Gabexate | 2 | 2012 | 3 | 0.130 |
Why?
|
| Phosphatidylinositols | 5 | 1997 | 69 | 0.120 |
Why?
|
| Esters | 2 | 2012 | 48 | 0.120 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2001 | 1704 | 0.120 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2010 | 4965 | 0.120 |
Why?
|
| Pyrrolidines | 3 | 2001 | 112 | 0.120 |
Why?
|
| Acute Disease | 4 | 2016 | 2491 | 0.120 |
Why?
|
| Heterografts | 2 | 2014 | 738 | 0.120 |
Why?
|
| Chemokine CXCL10 | 3 | 2000 | 104 | 0.120 |
Why?
|
| Antibodies, Blocking | 1 | 2015 | 94 | 0.120 |
Why?
|
| Sphingosine | 2 | 2005 | 59 | 0.120 |
Why?
|
| Chemokines, CXC | 3 | 2000 | 124 | 0.120 |
Why?
|
| Cell Cycle | 2 | 2002 | 2134 | 0.120 |
Why?
|
| Hep G2 Cells | 1 | 2014 | 146 | 0.110 |
Why?
|
| Endothelium, Vascular | 2 | 2009 | 863 | 0.110 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 1993 | 18 | 0.110 |
Why?
|
| Prognosis | 7 | 2017 | 22527 | 0.110 |
Why?
|
| Receptors, Cholinergic | 2 | 2001 | 98 | 0.110 |
Why?
|
| Inflammation Mediators | 2 | 2017 | 395 | 0.110 |
Why?
|
| Cullin Proteins | 1 | 2013 | 38 | 0.110 |
Why?
|
| Rats, Inbred Strains | 7 | 1992 | 450 | 0.110 |
Why?
|
| Positron-Emission Tomography | 3 | 2014 | 2199 | 0.110 |
Why?
|
| Nanotechnology | 1 | 2014 | 136 | 0.110 |
Why?
|
| Receptors, Neurotransmitter | 3 | 1988 | 32 | 0.110 |
Why?
|
| Trypsin Inhibitors | 3 | 1990 | 19 | 0.110 |
Why?
|
| F-Box Proteins | 1 | 2013 | 96 | 0.110 |
Why?
|
| Chemoprevention | 2 | 2014 | 251 | 0.110 |
Why?
|
| Carcinogenesis | 1 | 2019 | 1034 | 0.110 |
Why?
|
| Aminolevulinic Acid | 1 | 2013 | 20 | 0.110 |
Why?
|
| Cell Differentiation | 7 | 2013 | 4105 | 0.110 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 1993 | 242 | 0.110 |
Why?
|
| Secretory Pathway | 2 | 2011 | 14 | 0.110 |
Why?
|
| ErbB Receptors | 5 | 2015 | 2376 | 0.110 |
Why?
|
| Cell Death | 2 | 2014 | 685 | 0.110 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2014 | 604 | 0.110 |
Why?
|
| Kallikreins | 2 | 1991 | 86 | 0.110 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2013 | 616 | 0.100 |
Why?
|
| Electrophoretic Mobility Shift Assay | 2 | 2010 | 201 | 0.100 |
Why?
|
| Carcinoma | 4 | 2009 | 2610 | 0.100 |
Why?
|
| Diphosphonates | 1 | 2014 | 264 | 0.100 |
Why?
|
| S100 Calcium-Binding Protein A4 | 1 | 2012 | 47 | 0.100 |
Why?
|
| Drug Synergism | 4 | 2014 | 1355 | 0.100 |
Why?
|
| Zinc | 1 | 2013 | 194 | 0.100 |
Why?
|
| HMGB1 Protein | 1 | 2012 | 42 | 0.100 |
Why?
|
| Photochemotherapy | 1 | 2013 | 116 | 0.100 |
Why?
|
| Enzyme Induction | 1 | 2012 | 257 | 0.100 |
Why?
|
| Trefoil Factor-1 | 1 | 2011 | 16 | 0.100 |
Why?
|
| Polyamines | 1 | 1992 | 80 | 0.100 |
Why?
|
| Oligonucleotide Probes | 1 | 2011 | 153 | 0.100 |
Why?
|
| Energy Metabolism | 2 | 2018 | 984 | 0.100 |
Why?
|
| Neuroglia | 2 | 2004 | 251 | 0.100 |
Why?
|
| Cyclic AMP | 6 | 2004 | 381 | 0.100 |
Why?
|
| Transcription Factor AP-1 | 2 | 2004 | 248 | 0.100 |
Why?
|
| Mice, Mutant Strains | 1 | 2013 | 650 | 0.100 |
Why?
|
| Wound Healing | 1 | 2016 | 771 | 0.100 |
Why?
|
| Disaccharides | 1 | 2011 | 30 | 0.100 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2013 | 202 | 0.100 |
Why?
|
| Pancreatitis, Acute Necrotizing | 1 | 2011 | 10 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 3 | 2010 | 381 | 0.100 |
Why?
|
| Autoradiography | 1 | 2011 | 153 | 0.100 |
Why?
|
| Genetic Markers | 2 | 2020 | 1073 | 0.100 |
Why?
|
| Mast Cells | 1 | 2013 | 224 | 0.100 |
Why?
|
| Gene Knock-In Techniques | 1 | 2012 | 183 | 0.100 |
Why?
|
| I-kappa B Proteins | 4 | 2012 | 176 | 0.090 |
Why?
|
| Prodrugs | 1 | 2013 | 226 | 0.090 |
Why?
|
| Cytoplasm | 5 | 2020 | 702 | 0.090 |
Why?
|
| Heat-Shock Proteins | 2 | 2007 | 327 | 0.090 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2012 | 198 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2013 | 508 | 0.090 |
Why?
|
| Glucosides | 1 | 2011 | 61 | 0.090 |
Why?
|
| Insulin-Secreting Cells | 1 | 2012 | 158 | 0.090 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2015 | 497 | 0.090 |
Why?
|
| Glycosylation | 3 | 2007 | 229 | 0.090 |
Why?
|
| Receptor, Muscarinic M3 | 3 | 1999 | 21 | 0.090 |
Why?
|
| Sodium | 4 | 1992 | 336 | 0.090 |
Why?
|
| Diabetes Mellitus | 2 | 2018 | 1042 | 0.090 |
Why?
|
| Culture Techniques | 4 | 2004 | 142 | 0.090 |
Why?
|
| Caveolin 1 | 1 | 2011 | 201 | 0.090 |
Why?
|
| Cell Lineage | 2 | 2011 | 698 | 0.090 |
Why?
|
| Protein Isoforms | 3 | 2004 | 843 | 0.090 |
Why?
|
| Genes, fos | 2 | 2005 | 54 | 0.090 |
Why?
|
| Early Diagnosis | 1 | 2011 | 315 | 0.090 |
Why?
|
| In Situ Hybridization | 2 | 2002 | 1043 | 0.090 |
Why?
|
| Cell Growth Processes | 2 | 2009 | 336 | 0.090 |
Why?
|
| Adrenalectomy | 2 | 1989 | 195 | 0.090 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2011 | 224 | 0.090 |
Why?
|
| Tumor Burden | 2 | 2013 | 2033 | 0.090 |
Why?
|
| Interleukin-8 | 1 | 2012 | 527 | 0.090 |
Why?
|
| Genes | 2 | 2004 | 604 | 0.090 |
Why?
|
| Cytoplasmic Granules | 2 | 1993 | 85 | 0.090 |
Why?
|
| Culture Media | 3 | 2005 | 340 | 0.090 |
Why?
|
| Models, Animal | 2 | 2012 | 656 | 0.080 |
Why?
|
| Cell Culture Techniques | 3 | 2011 | 573 | 0.080 |
Why?
|
| Tetradecanoylphorbol Acetate | 3 | 2000 | 248 | 0.080 |
Why?
|
| Hedgehog Proteins | 1 | 2012 | 440 | 0.080 |
Why?
|
| Molecular Imaging | 1 | 2011 | 186 | 0.080 |
Why?
|
| Trypsin Inhibitor, Kunitz Soybean | 1 | 1989 | 4 | 0.080 |
Why?
|
| Furin | 1 | 2009 | 11 | 0.080 |
Why?
|
| Lipopolysaccharides | 1 | 2012 | 578 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2020 | 2050 | 0.080 |
Why?
|
| Proteomics | 2 | 2008 | 1424 | 0.080 |
Why?
|
| Pancreatic Elastase | 4 | 2011 | 35 | 0.080 |
Why?
|
| Cell Cycle Proteins | 2 | 2012 | 2112 | 0.080 |
Why?
|
| Models, Biological | 3 | 2019 | 3186 | 0.080 |
Why?
|
| Sensitivity and Specificity | 3 | 2007 | 5157 | 0.080 |
Why?
|
| Lipocalins | 1 | 2008 | 54 | 0.080 |
Why?
|
| RNA, Transfer | 1 | 1988 | 87 | 0.080 |
Why?
|
| Acute-Phase Proteins | 1 | 2008 | 84 | 0.080 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 3 | 1999 | 305 | 0.080 |
Why?
|
| Gastric Juice | 3 | 1982 | 17 | 0.080 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2009 | 333 | 0.080 |
Why?
|
| Serum | 1 | 2008 | 71 | 0.080 |
Why?
|
| Neuropilin-2 | 1 | 2008 | 21 | 0.080 |
Why?
|
| Caspase 3 | 1 | 2009 | 460 | 0.080 |
Why?
|
| DNA, Complementary | 2 | 2003 | 931 | 0.070 |
Why?
|
| Pancreatic Juice | 1 | 2007 | 12 | 0.070 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 1195 | 0.070 |
Why?
|
| Female | 18 | 2019 | 148834 | 0.070 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2007 | 26 | 0.070 |
Why?
|
| Regulatory Factor X Transcription Factors | 1 | 2007 | 21 | 0.070 |
Why?
|
| Plasma | 1 | 2008 | 146 | 0.070 |
Why?
|
| MicroRNAs | 2 | 2013 | 2882 | 0.070 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2009 | 322 | 0.070 |
Why?
|
| Transcription Factor CHOP | 1 | 2007 | 24 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 3 | 2017 | 1072 | 0.070 |
Why?
|
| Mesoderm | 1 | 2009 | 391 | 0.070 |
Why?
|
| Cell Hypoxia | 2 | 2008 | 353 | 0.070 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2007 | 39 | 0.070 |
Why?
|
| Forkhead Transcription Factors | 1 | 2011 | 762 | 0.070 |
Why?
|
| Calcimycin | 4 | 2002 | 52 | 0.070 |
Why?
|
| Mice, SCID | 2 | 2011 | 1825 | 0.070 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2007 | 62 | 0.070 |
Why?
|
| Epithelium | 1 | 2009 | 786 | 0.070 |
Why?
|
| Pericytes | 1 | 2007 | 90 | 0.070 |
Why?
|
| Insulin Resistance | 1 | 2012 | 718 | 0.070 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2008 | 191 | 0.070 |
Why?
|
| Paclitaxel | 1 | 2014 | 2114 | 0.070 |
Why?
|
| Colorectal Neoplasms | 2 | 2016 | 3707 | 0.070 |
Why?
|
| Wnt Proteins | 1 | 2009 | 384 | 0.070 |
Why?
|
| Chromatography, Affinity | 1 | 2006 | 144 | 0.070 |
Why?
|
| Second Messenger Systems | 2 | 1997 | 34 | 0.070 |
Why?
|
| Muscle Proteins | 1 | 2010 | 486 | 0.070 |
Why?
|
| Receptors, Glucocorticoid | 1 | 1988 | 207 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 5 | 2002 | 1117 | 0.070 |
Why?
|
| Benzamides | 1 | 2012 | 1879 | 0.070 |
Why?
|
| GPI-Linked Proteins | 2 | 2019 | 233 | 0.070 |
Why?
|
| Activating Transcription Factor 3 | 1 | 2006 | 30 | 0.070 |
Why?
|
| Genes, APC | 1 | 2006 | 72 | 0.070 |
Why?
|
| Cycloheximide | 2 | 2001 | 111 | 0.070 |
Why?
|
| Imidazoles | 1 | 2012 | 1065 | 0.070 |
Why?
|
| Receptor, Cholecystokinin B | 3 | 1998 | 4 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 3 | 2015 | 4468 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 3 | 2009 | 538 | 0.070 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2009 | 573 | 0.070 |
Why?
|
| Type C Phospholipases | 4 | 2005 | 62 | 0.070 |
Why?
|
| Gastrointestinal Agents | 1 | 1987 | 119 | 0.070 |
Why?
|
| Biological Transport | 4 | 2004 | 630 | 0.070 |
Why?
|
| Guanosine Triphosphate | 2 | 2024 | 105 | 0.070 |
Why?
|
| eIF-2 Kinase | 1 | 2007 | 166 | 0.070 |
Why?
|
| Epigenesis, Genetic | 1 | 2013 | 1439 | 0.060 |
Why?
|
| Molecular Chaperones | 1 | 2007 | 266 | 0.060 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2006 | 210 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2010 | 1276 | 0.060 |
Why?
|
| Culture Media, Serum-Free | 1 | 2005 | 79 | 0.060 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2006 | 159 | 0.060 |
Why?
|
| Feasibility Studies | 1 | 2011 | 2360 | 0.060 |
Why?
|
| Guinea Pigs | 4 | 2004 | 241 | 0.060 |
Why?
|
| beta-Galactosidase | 3 | 2006 | 272 | 0.060 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 2005 | 290 | 0.060 |
Why?
|
| Glycation End Products, Advanced | 1 | 2005 | 35 | 0.060 |
Why?
|
| Neurotransmitter Agents | 2 | 2004 | 171 | 0.060 |
Why?
|
| Interleukin-6 | 1 | 2010 | 1032 | 0.060 |
Why?
|
| GTPase-Activating Proteins | 1 | 2006 | 131 | 0.060 |
Why?
|
| Fibrosis | 3 | 2013 | 715 | 0.060 |
Why?
|
| Antibodies, Neutralizing | 2 | 2019 | 501 | 0.060 |
Why?
|
| Secretory Vesicles | 1 | 2005 | 41 | 0.060 |
Why?
|
| RNA Splicing | 1 | 2007 | 362 | 0.060 |
Why?
|
| Phorbols | 1 | 1984 | 11 | 0.060 |
Why?
|
| beta Catenin | 1 | 2009 | 689 | 0.060 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2005 | 89 | 0.060 |
Why?
|
| Nodose Ganglion | 1 | 2004 | 7 | 0.060 |
Why?
|
| Cholinergic Fibers | 1 | 2004 | 12 | 0.060 |
Why?
|
| Androgen-Binding Protein | 1 | 2004 | 34 | 0.060 |
Why?
|
| Phorbol Esters | 1 | 1984 | 42 | 0.060 |
Why?
|
| N-Methylscopolamine | 2 | 1999 | 2 | 0.060 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2004 | 20 | 0.060 |
Why?
|
| Tritium | 3 | 1993 | 266 | 0.060 |
Why?
|
| Sarcoma | 1 | 2015 | 1851 | 0.060 |
Why?
|
| Insulinoma | 1 | 2004 | 53 | 0.060 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2004 | 54 | 0.060 |
Why?
|
| Tamoxifen | 1 | 2008 | 875 | 0.060 |
Why?
|
| Alternative Splicing | 1 | 2007 | 610 | 0.060 |
Why?
|
| Postprandial Period | 1 | 2004 | 83 | 0.060 |
Why?
|
| Reference Values | 4 | 1997 | 1127 | 0.060 |
Why?
|
| Genetic Vectors | 2 | 2002 | 1837 | 0.060 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2006 | 16740 | 0.060 |
Why?
|
| Myenteric Plexus | 1 | 2004 | 17 | 0.060 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2004 | 25 | 0.060 |
Why?
|
| Cloning, Molecular | 5 | 1996 | 1406 | 0.060 |
Why?
|
| Calreticulin | 1 | 2004 | 84 | 0.060 |
Why?
|
| Coculture Techniques | 2 | 2017 | 626 | 0.060 |
Why?
|
| Estrenes | 4 | 2005 | 28 | 0.060 |
Why?
|
| Smad3 Protein | 2 | 2004 | 121 | 0.060 |
Why?
|
| Ionophores | 2 | 2002 | 23 | 0.060 |
Why?
|
| Enteric Nervous System | 1 | 2004 | 43 | 0.060 |
Why?
|
| Egtazic Acid | 2 | 2000 | 58 | 0.060 |
Why?
|
| Taurocholic Acid | 1 | 2003 | 16 | 0.060 |
Why?
|
| Aldosterone | 3 | 1991 | 78 | 0.060 |
Why?
|
| Fluorouracil | 2 | 2009 | 1990 | 0.060 |
Why?
|
| Devazepide | 3 | 1997 | 5 | 0.060 |
Why?
|
| ROC Curve | 1 | 2007 | 1250 | 0.060 |
Why?
|
| Growth Substances | 1 | 2004 | 325 | 0.060 |
Why?
|
| Benzodiazepinones | 3 | 1997 | 12 | 0.060 |
Why?
|
| Endothelial Cells | 1 | 2009 | 1031 | 0.060 |
Why?
|
| Xenopus laevis | 5 | 1992 | 271 | 0.050 |
Why?
|
| STAT3 Transcription Factor | 1 | 2010 | 1131 | 0.050 |
Why?
|
| Exocytosis | 3 | 2008 | 117 | 0.050 |
Why?
|
| Serotonin | 1 | 2004 | 287 | 0.050 |
Why?
|
| Colony-Forming Units Assay | 2 | 2010 | 253 | 0.050 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2003 | 66 | 0.050 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2004 | 238 | 0.050 |
Why?
|
| Cyclin D1 | 2 | 2010 | 591 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 1 | 2004 | 328 | 0.050 |
Why?
|
| Immediate-Early Proteins | 1 | 2003 | 104 | 0.050 |
Why?
|
| Early Detection of Cancer | 1 | 2011 | 1344 | 0.050 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 1984 | 211 | 0.050 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2004 | 179 | 0.050 |
Why?
|
| Neural Pathways | 1 | 2004 | 311 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2004 | 294 | 0.050 |
Why?
|
| Poly A | 3 | 1992 | 96 | 0.050 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 1998 | 629 | 0.050 |
Why?
|
| Mice, Knockout | 4 | 2017 | 5692 | 0.050 |
Why?
|
| Leucine | 3 | 1992 | 357 | 0.050 |
Why?
|
| rab3 GTP-Binding Proteins | 1 | 2002 | 18 | 0.050 |
Why?
|
| Amphibians | 1 | 1982 | 5 | 0.050 |
Why?
|
| Ionomycin | 2 | 2000 | 35 | 0.050 |
Why?
|
| Pyrrolidinones | 3 | 2005 | 61 | 0.050 |
Why?
|
| DNA Probes | 3 | 1992 | 244 | 0.050 |
Why?
|
| Odds Ratio | 1 | 2007 | 2297 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2012 | 1415 | 0.050 |
Why?
|
| CpG Islands | 1 | 2004 | 669 | 0.050 |
Why?
|
| Genes, Dominant | 2 | 2001 | 356 | 0.050 |
Why?
|
| Cystic Fibrosis | 1 | 2004 | 291 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2012 | 6231 | 0.050 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2006 | 358 | 0.050 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2004 | 318 | 0.050 |
Why?
|
| Cell Membrane | 4 | 2005 | 880 | 0.050 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2001 | 71 | 0.050 |
Why?
|
| Recombination, Genetic | 2 | 2020 | 649 | 0.050 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2013 | 506 | 0.050 |
Why?
|
| Cyclins | 2 | 2001 | 465 | 0.050 |
Why?
|
| Cell Nucleus | 2 | 2000 | 1715 | 0.050 |
Why?
|
| Adenoma | 1 | 2006 | 738 | 0.050 |
Why?
|
| Inositol Phosphates | 2 | 2005 | 26 | 0.050 |
Why?
|
| Hydrolysis | 3 | 1995 | 236 | 0.050 |
Why?
|
| Genes, erbB-1 | 1 | 2001 | 104 | 0.050 |
Why?
|
| Progesterone | 3 | 1991 | 711 | 0.050 |
Why?
|
| Autoantibodies | 1 | 2004 | 606 | 0.050 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2001 | 160 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2000 | 1072 | 0.040 |
Why?
|
| Smad2 Protein | 1 | 2000 | 89 | 0.040 |
Why?
|
| Maleimides | 1 | 2000 | 22 | 0.040 |
Why?
|
| Acetylcysteine | 1 | 2001 | 133 | 0.040 |
Why?
|
| Flavonoids | 1 | 2001 | 199 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2020 | 40 | 0.040 |
Why?
|
| NF-KappaB Inhibitor alpha | 2 | 2012 | 137 | 0.040 |
Why?
|
| Collagen | 2 | 2016 | 723 | 0.040 |
Why?
|
| Logistic Models | 1 | 2007 | 3423 | 0.040 |
Why?
|
| Aorta | 1 | 2004 | 666 | 0.040 |
Why?
|
| Blotting, Northern | 3 | 2005 | 719 | 0.040 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2001 | 344 | 0.040 |
Why?
|
| raf Kinases | 1 | 2019 | 80 | 0.040 |
Why?
|
| Genes, src | 1 | 1999 | 28 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2006 | 1152 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 5776 | 0.040 |
Why?
|
| Enzyme Precursors | 2 | 1996 | 71 | 0.040 |
Why?
|
| Transforming Growth Factor alpha | 1 | 1999 | 94 | 0.040 |
Why?
|
| Drug Interactions | 2 | 2005 | 572 | 0.040 |
Why?
|
| Aerobiosis | 1 | 2019 | 31 | 0.040 |
Why?
|
| Endosomes | 1 | 2020 | 105 | 0.040 |
Why?
|
| Chelating Agents | 1 | 2000 | 131 | 0.040 |
Why?
|
| Liposomes | 2 | 2014 | 702 | 0.040 |
Why?
|
| Homeodomain Proteins | 3 | 2011 | 1124 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2020 | 6255 | 0.040 |
Why?
|
| Carcinogens | 1 | 2000 | 390 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 1999 | 273 | 0.040 |
Why?
|
| National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) | 1 | 2018 | 10 | 0.040 |
Why?
|
| Intracellular Fluid | 2 | 2011 | 48 | 0.040 |
Why?
|
| Ribonucleases | 2 | 1989 | 92 | 0.040 |
Why?
|
| Lac Operon | 2 | 2011 | 133 | 0.040 |
Why?
|
| Autocrine Communication | 1 | 2018 | 88 | 0.040 |
Why?
|
| Pancreatic Cyst | 1 | 2019 | 111 | 0.040 |
Why?
|
| Lung | 1 | 2009 | 3287 | 0.040 |
Why?
|
| PPAR gamma | 1 | 2019 | 224 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2007 | 4963 | 0.040 |
Why?
|
| Dietary Carbohydrates | 1 | 2019 | 128 | 0.040 |
Why?
|
| Neutralization Tests | 1 | 2018 | 236 | 0.040 |
Why?
|
| Protein Biosynthesis | 3 | 1988 | 986 | 0.040 |
Why?
|
| Cattle | 2 | 1997 | 818 | 0.040 |
Why?
|
| Rana pipiens | 3 | 1982 | 39 | 0.040 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2019 | 185 | 0.040 |
Why?
|
| Chymotrypsin | 2 | 1989 | 37 | 0.040 |
Why?
|
| Clone Cells | 1 | 1999 | 589 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2018 | 1462 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2014 | 7786 | 0.040 |
Why?
|
| Aged | 7 | 2016 | 73579 | 0.040 |
Why?
|
| Protein Transport | 1 | 2020 | 738 | 0.040 |
Why?
|
| Galectins | 1 | 2017 | 73 | 0.040 |
Why?
|
| Macromolecular Substances | 3 | 2005 | 340 | 0.040 |
Why?
|
| Arachidonic Acid | 1 | 1997 | 120 | 0.040 |
Why?
|
| Neutrophils | 1 | 2002 | 855 | 0.040 |
Why?
|
| Ubiquitination | 1 | 2020 | 578 | 0.040 |
Why?
|
| Chemokine CCL2 | 1 | 1997 | 193 | 0.030 |
Why?
|
| Cathepsin B | 1 | 1996 | 35 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2010 | 631 | 0.030 |
Why?
|
| Indoles | 2 | 2000 | 1028 | 0.030 |
Why?
|
| Prostatic Neoplasms | 2 | 2012 | 5867 | 0.030 |
Why?
|
| Structure-Activity Relationship | 2 | 1996 | 974 | 0.030 |
Why?
|
| Receptors, Somatotropin | 1 | 1996 | 19 | 0.030 |
Why?
|
| Anisomycin | 1 | 1996 | 12 | 0.030 |
Why?
|
| Mice, Inbred ICR | 2 | 2010 | 229 | 0.030 |
Why?
|
| Middle Aged | 7 | 2016 | 90495 | 0.030 |
Why?
|
| Protein Kinases | 2 | 1999 | 889 | 0.030 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2017 | 289 | 0.030 |
Why?
|
| Binding Sites | 5 | 2005 | 2249 | 0.030 |
Why?
|
| Muscarinic Agonists | 1 | 1995 | 42 | 0.030 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 1997 | 188 | 0.030 |
Why?
|
| Growth Hormone | 1 | 1996 | 215 | 0.030 |
Why?
|
| United States | 2 | 2018 | 15813 | 0.030 |
Why?
|
| Bromodeoxyuridine | 2 | 2006 | 128 | 0.030 |
Why?
|
| Submandibular Gland | 1 | 2015 | 18 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2015 | 31110 | 0.030 |
Why?
|
| Nucleotides | 1 | 1996 | 174 | 0.030 |
Why?
|
| Antimetabolites | 2 | 2006 | 76 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2007 | 437 | 0.030 |
Why?
|
| Receptors, Neuropeptide | 1 | 1995 | 24 | 0.030 |
Why?
|
| Estrogen Receptor alpha | 1 | 2019 | 691 | 0.030 |
Why?
|
| Albumins | 2 | 2014 | 263 | 0.030 |
Why?
|
| Integrin beta Chains | 1 | 2015 | 37 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 1995 | 426 | 0.030 |
Why?
|
| Extracellular Space | 1 | 2015 | 135 | 0.030 |
Why?
|
| Adult | 5 | 2016 | 82023 | 0.030 |
Why?
|
| Pertussis Toxin | 2 | 2005 | 62 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 2 | 2011 | 2419 | 0.030 |
Why?
|
| Laminin | 1 | 2015 | 208 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2009 | 300 | 0.030 |
Why?
|
| Cluster Analysis | 2 | 2009 | 1076 | 0.030 |
Why?
|
| Postmenopause | 1 | 2016 | 365 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 2 | 2014 | 1188 | 0.030 |
Why?
|
| Nanomedicine | 1 | 2014 | 53 | 0.030 |
Why?
|
| Luminescent Measurements | 1 | 2014 | 157 | 0.030 |
Why?
|
| Thapsigargin | 1 | 1993 | 43 | 0.030 |
Why?
|
| Binding, Competitive | 3 | 1996 | 327 | 0.030 |
Why?
|
| Terpenes | 1 | 1993 | 41 | 0.030 |
Why?
|
| Calcium-Transporting ATPases | 1 | 1993 | 70 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 1986 | 241 | 0.030 |
Why?
|
| Cetuximab | 1 | 2015 | 474 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 1995 | 1837 | 0.030 |
Why?
|
| Adaptation, Physiological | 1 | 1995 | 339 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2018 | 9278 | 0.030 |
Why?
|
| Biocompatible Materials | 1 | 2014 | 202 | 0.030 |
Why?
|
| Jurkat Cells | 1 | 2013 | 318 | 0.030 |
Why?
|
| Tryptases | 1 | 2013 | 45 | 0.030 |
Why?
|
| Benzylamines | 1 | 2013 | 98 | 0.030 |
Why?
|
| Cell Degranulation | 1 | 2013 | 46 | 0.030 |
Why?
|
| Phenylurea Compounds | 1 | 1997 | 600 | 0.030 |
Why?
|
| Alcohol Drinking | 1 | 2016 | 597 | 0.030 |
Why?
|
| Caloric Restriction | 1 | 2013 | 88 | 0.030 |
Why?
|
| Receptors, Tumor Necrosis Factor | 2 | 2006 | 206 | 0.030 |
Why?
|
| Genes, jun | 1 | 1992 | 41 | 0.030 |
Why?
|
| Interleukin-13 | 1 | 2013 | 127 | 0.030 |
Why?
|
| Smoothened Receptor | 1 | 2012 | 53 | 0.030 |
Why?
|
| Heterocyclic Compounds | 1 | 2013 | 117 | 0.030 |
Why?
|
| Phenylbutyrates | 1 | 2013 | 62 | 0.030 |
Why?
|
| Naphthalenes | 1 | 2013 | 84 | 0.030 |
Why?
|
| Lipase | 1 | 1993 | 119 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 3 | 1993 | 3463 | 0.030 |
Why?
|
| Organ Size | 2 | 2010 | 686 | 0.030 |
Why?
|
| Cdc20 Proteins | 1 | 2012 | 26 | 0.030 |
Why?
|
| Chymotrypsinogen | 1 | 1992 | 1 | 0.030 |
Why?
|
| Lysophospholipase | 1 | 1992 | 4 | 0.030 |
Why?
|
| Ornithine Decarboxylase Inhibitors | 1 | 1992 | 18 | 0.030 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2013 | 221 | 0.030 |
Why?
|
| Chromaffin Granules | 1 | 1992 | 1 | 0.030 |
Why?
|
| Collagen Type I | 1 | 2013 | 186 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 1995 | 746 | 0.030 |
Why?
|
| Anticarcinogenic Agents | 1 | 2014 | 368 | 0.020 |
Why?
|
| Eflornithine | 1 | 1992 | 60 | 0.020 |
Why?
|
| Substance P | 2 | 1995 | 75 | 0.020 |
Why?
|
| Biological Transport, Active | 2 | 1982 | 130 | 0.020 |
Why?
|
| Light | 1 | 2013 | 279 | 0.020 |
Why?
|
| Heparin-binding EGF-like Growth Factor | 1 | 2011 | 18 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 1997 | 1958 | 0.020 |
Why?
|
| Halogenation | 1 | 2011 | 12 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 1992 | 340 | 0.020 |
Why?
|
| Receptors, Histamine H2 | 1 | 1991 | 13 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2016 | 1471 | 0.020 |
Why?
|
| Adiposity | 1 | 2013 | 238 | 0.020 |
Why?
|
| Forkhead Box Protein M1 | 1 | 2011 | 115 | 0.020 |
Why?
|
| Comorbidity | 1 | 2018 | 2393 | 0.020 |
Why?
|
| Receptor, PAR-2 | 1 | 2011 | 5 | 0.020 |
Why?
|
| Receptors, Histamine H1 | 1 | 1991 | 6 | 0.020 |
Why?
|
| Breast Neoplasms | 2 | 2010 | 16242 | 0.020 |
Why?
|
| Blood Vessels | 1 | 2012 | 232 | 0.020 |
Why?
|
| Diphtheria Toxin | 1 | 2011 | 82 | 0.020 |
Why?
|
| Ovarian Neoplasms | 1 | 2007 | 4809 | 0.020 |
Why?
|
| Receptors, CXCR4 | 1 | 2013 | 276 | 0.020 |
Why?
|
| Receptor, PAR-1 | 1 | 2011 | 32 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2014 | 453 | 0.020 |
Why?
|
| Liver Regeneration | 1 | 2011 | 133 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2012 | 396 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2018 | 799 | 0.020 |
Why?
|
| Genes, myc | 1 | 1992 | 372 | 0.020 |
Why?
|
| Somatostatin | 2 | 1988 | 121 | 0.020 |
Why?
|
| Hydroxyurea | 1 | 1991 | 224 | 0.020 |
Why?
|
| Cell Communication | 1 | 2013 | 509 | 0.020 |
Why?
|
| Pancreatic Hormones | 1 | 1990 | 6 | 0.020 |
Why?
|
| Body Composition | 1 | 2013 | 600 | 0.020 |
Why?
|
| Macrophages | 1 | 2016 | 1334 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2014 | 663 | 0.020 |
Why?
|
| Risk Factors | 2 | 2018 | 17849 | 0.020 |
Why?
|
| NFATC Transcription Factors | 1 | 2010 | 96 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2011 | 757 | 0.020 |
Why?
|
| Calcineurin Inhibitors | 1 | 2010 | 68 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 2004 | 208 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2011 | 590 | 0.020 |
Why?
|
| Calcineurin | 1 | 2010 | 128 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2013 | 1458 | 0.020 |
Why?
|
| RNA, Untranslated | 1 | 2011 | 241 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2011 | 464 | 0.020 |
Why?
|
| Protease Inhibitors | 1 | 2010 | 206 | 0.020 |
Why?
|
| Dishevelled Proteins | 1 | 2009 | 55 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2011 | 896 | 0.020 |
Why?
|
| Phosphoproteins | 2 | 2009 | 1126 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 3840 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2013 | 1254 | 0.020 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2009 | 167 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2010 | 469 | 0.020 |
Why?
|
| Tacrolimus | 1 | 2010 | 347 | 0.020 |
Why?
|
| Microbial Collagenase | 1 | 1988 | 20 | 0.020 |
Why?
|
| Microvilli | 1 | 1988 | 89 | 0.020 |
Why?
|
| Food | 1 | 1989 | 151 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 1993 | 1091 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 2011 | 784 | 0.020 |
Why?
|
| Puromycin | 1 | 1987 | 18 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1989 | 628 | 0.020 |
Why?
|
| Semaphorins | 1 | 2008 | 37 | 0.020 |
Why?
|
| Permeability | 1 | 1988 | 160 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1991 | 562 | 0.020 |
Why?
|
| Half-Life | 1 | 1988 | 268 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2011 | 965 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 1 | 2007 | 207 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2010 | 12036 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2008 | 121 | 0.020 |
Why?
|
| Histamine | 2 | 1991 | 58 | 0.020 |
Why?
|
| Kidney | 1 | 1995 | 2101 | 0.020 |
Why?
|
| Bethanechol | 1 | 1986 | 2 | 0.020 |
Why?
|
| Bethanechol Compounds | 1 | 1986 | 3 | 0.020 |
Why?
|
| Methacholine Compounds | 1 | 1986 | 3 | 0.020 |
Why?
|
| Parasympatholytics | 1 | 1986 | 12 | 0.020 |
Why?
|
| Methacholine Chloride | 1 | 1986 | 29 | 0.020 |
Why?
|
| Scopolamine Derivatives | 1 | 1986 | 17 | 0.020 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 1987 | 111 | 0.020 |
Why?
|
| Glucose | 1 | 2012 | 1213 | 0.020 |
Why?
|
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2006 | 63 | 0.020 |
Why?
|
| Tyrosine | 2 | 1999 | 503 | 0.020 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 1986 | 33 | 0.020 |
Why?
|
| Secretory Rate | 1 | 1986 | 16 | 0.020 |
Why?
|
| Cadherins | 1 | 2009 | 658 | 0.020 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2011 | 1002 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2006 | 161 | 0.020 |
Why?
|
| Liver | 2 | 2013 | 3057 | 0.020 |
Why?
|
| Purines | 1 | 2007 | 271 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2006 | 228 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2008 | 1023 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2006 | 210 | 0.020 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2006 | 153 | 0.020 |
Why?
|
| Microscopy, Video | 1 | 2005 | 33 | 0.020 |
Why?
|
| Dibutyryl Cyclic GMP | 1 | 1984 | 3 | 0.020 |
Why?
|
| Phosphatidylethanolamine Binding Protein | 1 | 2004 | 7 | 0.020 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2005 | 50 | 0.020 |
Why?
|
| Adenosine Diphosphate Ribose | 1 | 2004 | 18 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2018 | 3561 | 0.020 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2005 | 71 | 0.010 |
Why?
|
| Microdissection | 1 | 2004 | 85 | 0.010 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2004 | 46 | 0.010 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2004 | 44 | 0.010 |
Why?
|
| Boronic Acids | 1 | 2006 | 355 | 0.010 |
Why?
|
| Bortezomib | 1 | 2006 | 551 | 0.010 |
Why?
|
| Receptors, Somatomedin | 1 | 1984 | 72 | 0.010 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2005 | 284 | 0.010 |
Why?
|
| Integrins | 1 | 2006 | 273 | 0.010 |
Why?
|
| COS Cells | 1 | 2005 | 417 | 0.010 |
Why?
|
| Receptors, Lysophospholipid | 1 | 2004 | 3 | 0.010 |
Why?
|
| Thermodynamics | 1 | 1984 | 195 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 2005 | 337 | 0.010 |
Why?
|
| Phosphates | 1 | 2005 | 178 | 0.010 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2004 | 34 | 0.010 |
Why?
|
| Liver Cirrhosis | 1 | 2011 | 1047 | 0.010 |
Why?
|
| Loss of Heterozygosity | 1 | 2006 | 623 | 0.010 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2004 | 39 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1984 | 556 | 0.010 |
Why?
|
| Sphingolipids | 1 | 2004 | 38 | 0.010 |
Why?
|
| Appetite Depressants | 1 | 1983 | 22 | 0.010 |
Why?
|
| Pyrazines | 1 | 2006 | 511 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 2006 | 479 | 0.010 |
Why?
|
| Cytosol | 1 | 2004 | 270 | 0.010 |
Why?
|
| Adenosine Triphosphate | 2 | 1996 | 580 | 0.010 |
Why?
|
| Genes, Neoplasm | 1 | 2004 | 314 | 0.010 |
Why?
|
| Temperature | 1 | 1984 | 534 | 0.010 |
Why?
|
| Vasoactive Intestinal Peptide | 2 | 1996 | 25 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2004 | 278 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2004 | 262 | 0.010 |
Why?
|
| Algorithms | 2 | 2004 | 3903 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2010 | 2176 | 0.010 |
Why?
|
| Lysine | 1 | 2005 | 426 | 0.010 |
Why?
|
| Calcium Channels | 1 | 2004 | 214 | 0.010 |
Why?
|
| Microinjections | 2 | 1992 | 104 | 0.010 |
Why?
|
| Ouabain | 1 | 1982 | 36 | 0.010 |
Why?
|
| Mitosis | 1 | 2005 | 681 | 0.010 |
Why?
|
| Protein Precursors | 1 | 2004 | 251 | 0.010 |
Why?
|
| Estradiol | 1 | 1986 | 828 | 0.010 |
Why?
|
| Plasmids | 1 | 2004 | 923 | 0.010 |
Why?
|
| Diet | 1 | 2010 | 1468 | 0.010 |
Why?
|
| Rana catesbeiana | 1 | 1982 | 3 | 0.010 |
Why?
|
| Freeze Fracturing | 1 | 1982 | 5 | 0.010 |
Why?
|
| GTP Phosphohydrolases | 1 | 2004 | 339 | 0.010 |
Why?
|
| Spectrophotometry, Atomic | 1 | 1981 | 14 | 0.010 |
Why?
|
| Bucladesine | 1 | 1981 | 32 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 4391 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2014 | 6765 | 0.010 |
Why?
|
| Cisplatin | 1 | 2009 | 2508 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2004 | 721 | 0.010 |
Why?
|
| Chlorides | 1 | 1982 | 137 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2006 | 1127 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2005 | 1250 | 0.010 |
Why?
|
| Genetic Therapy | 1 | 2009 | 1715 | 0.010 |
Why?
|
| Observer Variation | 1 | 2003 | 709 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 10268 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2008 | 1580 | 0.010 |
Why?
|
| Mitochondria | 1 | 1988 | 1292 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2016 | 13406 | 0.010 |
Why?
|
| Potassium | 1 | 1982 | 327 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 2002 | 220 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 1982 | 455 | 0.010 |
Why?
|
| Rabbits | 1 | 1982 | 1040 | 0.010 |
Why?
|
| Dogs | 2 | 1993 | 1082 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 1981 | 442 | 0.010 |
Why?
|
| Radiation, Ionizing | 1 | 2001 | 190 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2005 | 1736 | 0.010 |
Why?
|
| DNA, Antisense | 1 | 1999 | 44 | 0.010 |
Why?
|
| Butadienes | 1 | 1999 | 35 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 617 | 0.010 |
Why?
|
| Lymphoma | 1 | 1988 | 1516 | 0.010 |
Why?
|
| Pyridines | 1 | 2006 | 1310 | 0.010 |
Why?
|
| Mifepristone | 2 | 1991 | 180 | 0.010 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 1999 | 142 | 0.010 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2001 | 525 | 0.010 |
Why?
|
| Fetus | 1 | 1982 | 670 | 0.010 |
Why?
|
| Genotype | 1 | 2006 | 4245 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2004 | 3534 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 1999 | 751 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 7916 | 0.010 |
Why?
|
| Molecular Weight | 2 | 1988 | 714 | 0.010 |
Why?
|
| Receptors, Somatostatin | 2 | 1988 | 94 | 0.010 |
Why?
|
| Neoadjuvant Therapy | 1 | 2011 | 5246 | 0.010 |
Why?
|
| Software | 1 | 2005 | 1357 | 0.010 |
Why?
|
| MAP Kinase Kinase Kinase 4 | 1 | 1997 | 3 | 0.010 |
Why?
|
| Genes, p53 | 1 | 2002 | 1140 | 0.010 |
Why?
|
| Nucleoside-Diphosphate Kinase | 1 | 1996 | 15 | 0.010 |
Why?
|
| Antibodies | 1 | 1999 | 801 | 0.010 |
Why?
|
| Cell-Free System | 1 | 1996 | 174 | 0.010 |
Why?
|
| Pituitary Adenylate Cyclase-Activating Polypeptide | 1 | 1995 | 6 | 0.010 |
Why?
|
| Bradykinin | 1 | 1995 | 89 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2012 | 4839 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2001 | 1286 | 0.010 |
Why?
|
| Oligopeptides | 1 | 1997 | 450 | 0.010 |
Why?
|
| Nitriles | 1 | 1999 | 938 | 0.010 |
Why?
|
| Neuropeptides | 1 | 1995 | 160 | 0.010 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 1995 | 168 | 0.010 |
Why?
|
| Glioma | 1 | 2005 | 1986 | 0.010 |
Why?
|
| Horses | 1 | 1993 | 85 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1993 | 326 | 0.010 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 1992 | 27 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2013 | 33840 | 0.010 |
Why?
|
| Dopamine beta-Hydroxylase | 1 | 1992 | 38 | 0.010 |
Why?
|
| Biological Evolution | 1 | 1993 | 289 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1992 | 579 | 0.010 |
Why?
|
| Cimetidine | 1 | 1991 | 28 | 0.010 |
Why?
|
| Diphenhydramine | 1 | 1991 | 20 | 0.010 |
Why?
|
| Norepinephrine | 1 | 1992 | 285 | 0.010 |
Why?
|
| Parietal Cells, Gastric | 1 | 1991 | 45 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1991 | 413 | 0.010 |
Why?
|
| Hormones | 1 | 1991 | 284 | 0.010 |
Why?
|
| Swine | 1 | 1993 | 1513 | 0.010 |
Why?
|
| Immunosorbent Techniques | 1 | 1988 | 53 | 0.000 |
Why?
|
| Pregnancy | 1 | 1982 | 7916 | 0.000 |
Why?
|
| Exocrine Glands | 1 | 1988 | 14 | 0.000 |
Why?
|
| Hybridomas | 1 | 1988 | 68 | 0.000 |
Why?
|
| Adenylyl Cyclases | 1 | 1988 | 102 | 0.000 |
Why?
|
| Histocytochemistry | 1 | 1988 | 194 | 0.000 |
Why?
|
| Hemin | 1 | 1987 | 29 | 0.000 |
Why?
|
| Feedback | 1 | 1989 | 224 | 0.000 |
Why?
|
| Methionine | 1 | 1987 | 170 | 0.000 |
Why?
|
| Immunization | 1 | 1988 | 383 | 0.000 |
Why?
|
| RNA | 1 | 1991 | 1057 | 0.000 |
Why?
|
| Intestine, Small | 1 | 1988 | 524 | 0.000 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1999 | 5603 | 0.000 |
Why?
|